Egfr mutation status in ansclc patients (locally advanced and/or metastatic disease) with adenocarcinoma and non-adenocarcinoma histologies. Clinical Trials

Delta Trials tracks 1 clinical trial for Egfr mutation status in ansclc patients (locally advanced and/or metastatic disease) with adenocarcinoma and non-adenocarcinoma histologies. in its publicly accessible dataset. Among the listed trials, 0 open for participant enrollment and 1 trial have reached completion. This research is carried out at 57 clinical sites around the world. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.